Effects of Travoprost on Neovascular Glaucoma

Overview

Prostaglandin analogues have not been used in the treatment of neovascular glaucoma because of suspicious lack of efficacy. This study aims at assessing the effect of travoprost on neovascular glaucoma.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Double

Interventions

  • Drug: Travoprost

Clinical Trial Outcome Measures

Primary Measures

  • Intraocular pressure

Secondary Measures

  • Inflammation

Participating in This Clinical Trial

Inclusion Criteria

  • Neovascular glaucoma of known cause – Older than 18 years – Previously submitted to retinal photocoagulation – Under medical treatment to glaucoma Exclusion Criteria:

  • Need of antiglaucomatous surgery – Previous ocular surgery in the last 6 months – Pregnancy

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Federal University of São Paulo
  • Overall Official(s)
    • Luiz A Melo Jr, MD, Principal Investigator, Federal University of São Paulo

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.